<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02380326</url>
  </required_header>
  <id_info>
    <org_study_id>150302V02</org_study_id>
    <nct_id>NCT02380326</nct_id>
  </id_info>
  <brief_title>Innovation in Endobronchial Sampling</brief_title>
  <official_title>Innovation in Endobronchial Sampling : Integration of Virtual Bronchoscopic Navigation in the Current Diagnostic Algorithm and the Use of Micro-CT for Tissue Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluating an integrated diagnostic work-up of virtual navigation bronchoscopy (VNB),
      confocal laser endomicroscopy and micro computerized tomography (micro-CT) in the diagnostic
      path of pulmonary lesions in the non-oncological patient.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The region(s) of interest that has/have to be sampled, will be selected upfront. Guided by
      the endobronchial pathway that is created by virtual bronchoscopy, the flexible bronchoscope
      will be navigated to the regions of interest and an optical biopsy of the region will be
      obtained using pCLE. One biopsy sample will be processed in the endoscopy suite to be able to
      prepare it for micro-CT analysis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic yield</measure>
    <time_frame>postprocedural</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Diffuse Interstitial Lung Disease</condition>
  <arm_group>
    <arm_group_label>Lung transplant recipients</arm_group_label>
    <description>Lung transplant recipients with diffuse parenchymal abnormalities subjected to advanced endoscopic imaging modalities</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diffuse intersitial lung disease</arm_group_label>
    <description>Patients suffering from diffuse intersitial lung disease without a certain diagnosis subjected to advanced endoscopic imaging modalities</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Advanced endoscopic imaging modalities</intervention_name>
    <description>Virtual bronchoscopic navigation, confocal laser endomicroscopy, micro CT</description>
    <arm_group_label>Lung transplant recipients</arm_group_label>
    <arm_group_label>Diffuse intersitial lung disease</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      transbronchial biopsy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Lung transplant recipients and diffuse interstitial lung disease without certain diagnosis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presence of diffuse pulmonary disease necessitating bronchoscopic evaluation.

          -  Informed consent available

          -  Age &gt; 18

          -  FVC &gt; 50%pred

          -  DLCO &gt; 35%pred

          -  PaO2 &gt; 55 mmHg, pCO2 &lt; 45 mmHg (ambient air)

          -  No exclusion criteria

        Exclusion Criteria:

          -  Age &gt; 75

          -  Systolic arterial pressure in the pulmonary artery : PAPS &gt;40mmHg

          -  Platelet count &lt;100000/Âµl

          -  INR &gt; 1.4

          -  BMI &gt;30

          -  Diffuse bullous lung disease

          -  Active anti-platelet or anticoagulant treatment

          -  Active heart failure or unstable coronary heart disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonas Yserbyt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonas Yserbyt, MD</last_name>
      <phone>+3216332211</phone>
      <email>jonas.yserbyt@uzleuven.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2015</study_first_submitted>
  <study_first_submitted_qc>March 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2015</study_first_posted>
  <last_update_submitted>May 23, 2018</last_update_submitted>
  <last_update_submitted_qc>May 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Yserbyt Jonas</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

